By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Development of clinical and preclinical product candidates focused on addressing unmet medical needs13.86M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States13.86M100.00%